Jim Simons
INBX

Jim Simons’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Jim Simons’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-92,300
Closed -$2.4M – 4328
2023
Q2 		$2.4M Sell
92,300
-121,200
-57% -$2.83M ﹤0.01% 1876
2023
Q1 		$4.03M Buy
+213,500
New +$4.97M 0.01% 1598

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Jim Simons's INBX Position: Q3 2023 in Review

Jim Simons sold out of Inhibrx, Inc. Common Stock (INBX) in Q3 2023, closing a stake of 92,300 shares — an estimated $2.4M sold.

Jim Simons first reported a position in INBX in Q1 2023 and held it in 2 quarters. The position peaked at $4.03M in Q1 2023. 111 funds tracked by Wall St. Rank hold INBX as of Q3 2023.

  • Jim Simons reported no remaining Inhibrx, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Jim Simons sold 92,300 Inhibrx, Inc. Common Stock shares in Q3 2023, an estimated $2.4M.
  • Jim Simons first reported a position in Inhibrx, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
  • Jim Simons's Inhibrx, Inc. Common Stock position peaked at $4.03M in Q1 2023.
  • 111 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q3 2023.

Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.